• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    Champions Oncology, Inc. (CSBR)

    -Other OTC
    0.55 Down 0.03(5.16%) Dec 17, 3:48PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Champions Oncology, Inc.
    One University Plaza
    Suite 307
    Hackensack, NJ 07601
    United States - Map
    Phone: 201-808-8400
    Website: http://www.championsoncology.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:60

    Business Summary 

    Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including non-core related POS products that provide access to oncologists in tumor types and patientÂ’s history of treatment; and gene sequencing that analyzes the genetic makeup of patientÂ’s tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies, which uses vivo studies and bioinformatics analysis to predict the efficacy of experimental oncology drugs or approved drugs as stand-alone therapies or in combination with other drugs. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Champions Oncology, Inc.

    Key Executives 
     PayExercised
    Mr. Joel Ackerman , 48
    Chief Exec. Officer, Sec. and Director
    53.00K0.00
    Dr. Ronnie Morris M.D., 47
    Pres and Director
    43.00K0.00
    Mr. James J. Mcgorry , 58
    Exec. VP and Gen. Mang. of The Translational Oncology Solutions Bus.
    181.00K0.00
    Mr. James M. Martell , 67
    Founder and Consultant
    N/AN/A
    Mr. David Barry Miller , 45
    VP of Fin.
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders